ArticleProbiotics and antimicrobial proteins2026
Effects of Bacillus-Based Probiotic Supplementation on Growth Performance, Antioxidant Capacity, Immunity, and Gut Health of PEDV-Infected Piglets.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Host-derived Limosilactobacillus reuteri R30 and Cytobacillus solani Y5 improve growth performance and intestinal health of Danzhou chickens by regulating the jejunal microbiota.Poultry science · 2026Article
- Effect ofAnimals : an open access journal from MDPI · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
Abstract
This experiment investigated the effects of dietary supplementation with GutPlus® Virsorb probiotic on piglets infected with porcine epidemic diarrhea virus (PEDV). Seventy-two Duroc × Landrace × Yorkshire weaned piglets (21 days of age, 5.51 ± 0.44 kg) were randomly divided into: the CON1 group (negative control, basal diet), the CON2 group (positive control, basal diet), and the GutPlus® Virsorb group (basal diet + 500 g/t GutPlus® Virsorb). At 28 days of age, piglets in the CON2 and GutPlus® Virsorb groups received 40 mL PEDV (8.58 × 10
Indexed as
Identifiers
40748444What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.